Form 4: Adagio Medical Holdings Director Acquires Stock Options

Director James L. Cox acquires non-qualified stock options in Adagio Medical Holdings, Inc. under the company's 2024 Equity Incentive Plan.

Summary

• James L. Cox, a director of Adagio Medical Holdings, Inc., acquired non-qualified stock options on March 20, 2025.
• These options were granted under the Issuer's 2024 Equity Incentive Plan.
• One option grants the right to buy 90,000 shares of common stock at $0.865 per share, vesting monthly over three years starting July 31, 2024, and expiring on July 31, 2034.
• The other option grants the right to buy 364,000 shares of common stock at $0.865 per share, is fully vested as of the grant date, and expires on March 20, 2035.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. It indicates confidence in the company's future, but doesn't provide specific positive or negative information.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule of one option encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting and expiration dates of the stock options.

Industry Context

Stock options are a common form of executive compensation in the medical device industry, used to incentivize performance and align management interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in growth-oriented sectors like medical technology.
• Companies like Medtronic, Boston Scientific, and Abbott also utilize stock options as part of their executive compensation plans.
• The vesting schedules and exercise prices are generally determined based on industry benchmarks and company-specific performance metrics.

Stakeholder Impact

• The stock option grants could potentially dilute existing shareholders if the options are exercised.
• The grants incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

stock options, Adagio Medical Holdings, director, equity incentive plan, beneficial ownership, ADGM